60 Degrees Pharmaceuticals Announces 2024 Annual Results

Provided By GlobeNewswire

Last update: Mar 28, 2025

WASHINGTON, March 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, reported today their financial results for the 2024 fiscal year, ended December 31, 2024.

Read more at globenewswire.com

60 DEGREES PHARMA INC

NASDAQ:SXTP (10/6/2025, 6:08:19 PM)

1.48

+0.06 (+4.23%)

SXTP Overview

SXTP Technical Analysis Report

SXTP Fundamental Analysis Report

60 DEGREES PHARMA INC-28

NASDAQ:SXTPW (10/6/2025, 2:52:43 PM)

0.0468

+0.01 (+18.18%)